INSIGHTS ON DRUG DISCOVERY
-
![iStock-1191001266-tablet-pill]( "Reduce Costly Scale-Up Problems")
Reduce Costly Scale-Up ProblemsScaling a new drug formulation from development to manufacturing often presents challenges, but there are ways to minimize deviations and streamline your transition.
-
![Scientists laboratory research-GettyImages-1938554515]( "Host Cell Impurities, Bioassays, Micro-Flow Imaging")
Host Cell Impurities, Bioassays, Micro-Flow ImagingEnsuring the safety and efficacy of cutting-edge biopharmaceuticals hinges on meticulous quality control measures. Explore the role of qPCR and MFI in safeguarding drugs from potential contamination.
-
![GettyImages-827581056 scientists]( "The Role Of Early Characterization Studies In The Assessment Of Advanced Therapeutic Potency")
The Role Of Early Characterization Studies In The Assessment Of Advanced Therapeutic PotencyEarly product characterization can serve to uncover crucial information about an advanced therapeutic candidate, affording new insight into its CQAs and helping to shape better analytical assays.
-
![GettyImages-1494104649 AI]( "The Write Side Of AI: Helping Hands, Not Replacement Plans")
The Write Side Of AI: Helping Hands, Not Replacement PlansAI applications in medical writing are in their infancy, and the technology suffers several shortcomings including plagiarism, copyright infringement, and misinformation dissemination.
-
Bacteria Media Optimization Using In Silico Strategies2/21/2024
Determining ideal media composition for a bacteria is critical because it fosters a satisfactory grow rate, allowing the bacteria to reach the required growth yield.
-
The Process Of Developing Monoclonal Antibodies For Clinical Use1/25/2024
Explore the potential of mAbs in treating diverse conditions, from cancer to infectious diseases, and learn about their transformation from scientific breakthroughs to life-changing therapies.
-
Quality Roundtable: Optimizing Biologics Manufacturing Processes With Raw Materials1/24/2024
Improve your commercial manufacturing process with advice from regulatory and raw materials experts on the development journey from pre-clinical to licensure.
-
Leveraging Stable Pool Material To Expedite The Path To IND1/10/2024
Review the efficacy of fast stable pools in generating purified product at an early stage and learn how to accelerate the journey toward first-in-human trials and proof-of-concept studies.
-
Potent Rifampicin Derivatives Can Clear MRSA Infections At Single Low Doses When Concomitantly Dosed With Vancomycin1/4/2024
Multidrug-resistant bacteria are rendering antibiotics ineffective. Review preclinical results of a potent macrocycle derivative and why collaboration is crucial to transition discoveries into treatments.
DRUG DISCOVERY SOLUTIONS
-
![GettyImages-871317164-inhalation-inhaler]( "Designed For Inhalation: Pulmonary And Nasal Delivery")
Our newly expanded in-house capabilities span clinical and commercial scale manufacturing for DPIs, unit-dose, bi-dose and preserved multi-dose nasal sprays.
-
Successful drug product development should integrate formulation, manufacturing process, primary packaging, device and delivery to the patient. Lonza’s Drug Product Services (DPS) offering delivers a holistic approach to DP development that anticipates and prevents problems early, and ensures the result is a product that is fit for purpose.
-
![GettyImages-530818462-bioreactor-development-lab]( "CHEF1™ Expression Technology")
The platform accelerates development of cell lines for cGMP production by using robust procedures and reliable raw materials, including chemically defined media, adapted Chinese hamster ovary (CHO) cells, and proprietary expression plasmids, to rapidly produce high levels of recombinant protein.
-
![GettyImages-1434150674-lab-microscope-team]( "Integrated Drug Discovery")
Finding a partner with integrated services is crucial for accelerating timelines and accessing solutions with comprehensive expertise, all while removing risk from the drug product lifecycle.
-
![Scientist research laboratory pipette GettyImages-487041629]( "SUREmAb™ - Monoclonal Antibody Development, The Way It's Meant To Be")
Leverage robust development strategies and enable an optimized process for mAb development and manufacturing, efficiency and speed with exceptional quality, and high titers with lower-cost workflows for maximum ROI.
